Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV‐infected subjects View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1995-07-16

AUTHORS

Ruiwen Zhang, Jieming Yan, Harout Shahinian, Girish Amin, Zhihong Lu, Tiepu Liu, Michael S. Saag, Zhiwei Jiang, Jamal Temsamani, R. Russell Martin, Paul J. Schechter, Sudhir Agrawal, Robert B. Diasio

ABSTRACT

Human pharmacokinetics of an antisense oligodeoxynucleotide phosphorothioate (GEM 91) developed as an anti-human immunodeficiency virus (HIV) agent was carried out in this study. 35S-Labeled GEM 91 was administered to six HIV-infected individuals by means of 2-hour intravenous infusions at a dose of 0.1 mg/kg. Plasma disappearance curves for GEM 91-derived radioactivity could be described by the sum of two exponentials, with half-life values of 0.18 +/- 0.04 and 26.71 +/- 1.67 hours. The radioactivity in plasma was further evaluated by polyacrylamide gel electrophoresis, showing the presence of both intact GEM 91 and lower molecular weight metabolites. Urinary excretion represented the major pathway of elimination, with 49.15% +/- 6.80% of the administered dose excreted within 24 hours and 70.37% +/- 6.72% over 96 hours after dosing. The radioactivity in urine was associated with lower molecular weight metabolites. No drug-related toxicity was observed. More... »

PAGES

44-53

References to SciGraph publications

  • 1993-08-31. Oligodeoxyribonucleotides Synthesis in PROTOCOLS FOR OLIGONUCLEOTIDES AND ANALOGS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1016/0009-9236(95)90071-3

    DOI

    http://dx.doi.org/10.1016/0009-9236(95)90071-3

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1026112658

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/7628182


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical Microbiology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antiviral Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Base Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chromatography, High Pressure Liquid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Electrophoresis, Polyacrylamide Gel", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "HIV Infections", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Infusions, Intravenous", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oligodeoxyribonucleotides, Antisense", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oligonucleotides, Antisense", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sulfur Radioisotopes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Thionucleotides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tissue Distribution", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhang", 
            "givenName": "Ruiwen", 
            "id": "sg:person.011364334577.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011364334577.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yan", 
            "givenName": "Jieming", 
            "id": "sg:person.01331501663.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331501663.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Shahinian", 
            "givenName": "Harout", 
            "id": "sg:person.0671453264.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671453264.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Amin", 
            "givenName": "Girish", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lu", 
            "givenName": "Zhihong", 
            "id": "sg:person.01306056120.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306056120.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liu", 
            "givenName": "Tiepu", 
            "id": "sg:person.01165601710.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165601710.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Saag", 
            "givenName": "Michael S.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jiang", 
            "givenName": "Zhiwei", 
            "id": "sg:person.016234157744.48", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016234157744.48"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Temsamani", 
            "givenName": "Jamal", 
            "id": "sg:person.0703710210.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703710210.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Martin", 
            "givenName": "R. Russell", 
            "id": "sg:person.01352605264.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352605264.31"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Schechter", 
            "givenName": "Paul J.", 
            "id": "sg:person.01106771602.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106771602.20"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Agrawal", 
            "givenName": "Sudhir", 
            "id": "sg:person.01124454740.04", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hybridon, Inc., Worcester, Mass., USA", 
              "id": "http://www.grid.ac/institutes/grid.452508.e", 
              "name": [
                "Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA", 
                "Hybridon, Inc., Worcester, Mass., USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Diasio", 
            "givenName": "Robert B.", 
            "id": "sg:person.01214146430.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214146430.55"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1385/0-89603-281-7:33", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014426169", 
              "https://doi.org/10.1385/0-89603-281-7:33"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1995-07-16", 
        "datePublishedReg": "1995-07-16", 
        "description": "Human pharmacokinetics of an antisense oligodeoxynucleotide phosphorothioate (GEM 91) developed as an anti-human immunodeficiency virus (HIV) agent was carried out in this study. 35S-Labeled GEM 91 was administered to six HIV-infected individuals by means of 2-hour intravenous infusions at a dose of 0.1 mg/kg. Plasma disappearance curves for GEM 91-derived radioactivity could be described by the sum of two exponentials, with half-life values of 0.18 +/- 0.04 and 26.71 +/- 1.67 hours. The radioactivity in plasma was further evaluated by polyacrylamide gel electrophoresis, showing the presence of both intact GEM 91 and lower molecular weight metabolites. Urinary excretion represented the major pathway of elimination, with 49.15% +/- 6.80% of the administered dose excreted within 24 hours and 70.37% +/- 6.72% over 96 hours after dosing. The radioactivity in urine was associated with lower molecular weight metabolites. No drug-related toxicity was observed.", 
        "genre": "article", 
        "id": "sg:pub.10.1016/0009-9236(95)90071-3", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1017409", 
            "issn": [
              "0009-9236", 
              "1532-6535"
            ], 
            "name": "Clinical Pharmacology & Therapeutics", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "58"
          }
        ], 
        "keywords": [
          "antisense oligodeoxynucleotide phosphorothioate", 
          "GEM 91", 
          "anti-human immunodeficiency virus agents", 
          "drug-related toxicity", 
          "oligodeoxynucleotide phosphorothioates", 
          "plasma disappearance curve", 
          "intravenous infusion", 
          "urinary excretion", 
          "administered dose", 
          "low molecular weight metabolites", 
          "virus agents", 
          "human pharmacokinetics", 
          "disappearance curve", 
          "weight metabolites", 
          "HIV", 
          "pharmacokinetics", 
          "dose", 
          "hours", 
          "half-life values", 
          "radioactivity", 
          "metabolites", 
          "major pathway", 
          "infusion", 
          "excretion", 
          "urine", 
          "polyacrylamide gel electrophoresis", 
          "gel electrophoresis", 
          "toxicity", 
          "subjects", 
          "agents", 
          "phosphorothioate", 
          "pathway", 
          "individuals", 
          "plasma", 
          "elimination", 
          "study", 
          "presence", 
          "electrophoresis", 
          "curves", 
          "means", 
          "values", 
          "sum", 
          "exponential"
        ], 
        "name": "Pharmacokinetics of an anti\u2014human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV\u2010infected subjects", 
        "pagination": "44-53", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1026112658"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1016/0009-9236(95)90071-3"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "7628182"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1016/0009-9236(95)90071-3", 
          "https://app.dimensions.ai/details/publication/pub.1026112658"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:48", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_290.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1016/0009-9236(95)90071-3"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1016/0009-9236(95)90071-3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1016/0009-9236(95)90071-3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1016/0009-9236(95)90071-3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1016/0009-9236(95)90071-3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    254 TRIPLES      21 PREDICATES      84 URIs      75 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1016/0009-9236(95)90071-3 schema:about N0534f588f6c64319ac520fa9a5300752
    2 N0a6bb8b81ed249849321686b332f814c
    3 N42aaad23e74f4e40aa794b7245d32942
    4 N4cc1358fdca848d68f5b86a7c640f691
    5 N5d04996050a946999641942559e6ce75
    6 N65edff04ac0e4bfa84037026ca00380b
    7 N86c59def7e8d4ef8ad639827c30beebf
    8 Na6ae597615aa48d1afa2aa0eeca5dfc8
    9 Nabef95996c1344a797d38c6d94690330
    10 Nb58879739c514dc1b5521079e1f7f88e
    11 Nb865a0d0373a46f797481083adc4e13f
    12 Nc000fd6f9115436abd97837b7deae83d
    13 Nc4630672d6ce4522adc54b9a93cddcdf
    14 Nd9601b3ff28440679bf0ffc41691b773
    15 Ndab48c3d4809489f827bd243a15b1c93
    16 anzsrc-for:11
    17 anzsrc-for:1108
    18 schema:author N44de35d3de9f436db3d55a66eba21034
    19 schema:citation sg:pub.10.1385/0-89603-281-7:33
    20 schema:datePublished 1995-07-16
    21 schema:datePublishedReg 1995-07-16
    22 schema:description Human pharmacokinetics of an antisense oligodeoxynucleotide phosphorothioate (GEM 91) developed as an anti-human immunodeficiency virus (HIV) agent was carried out in this study. 35S-Labeled GEM 91 was administered to six HIV-infected individuals by means of 2-hour intravenous infusions at a dose of 0.1 mg/kg. Plasma disappearance curves for GEM 91-derived radioactivity could be described by the sum of two exponentials, with half-life values of 0.18 +/- 0.04 and 26.71 +/- 1.67 hours. The radioactivity in plasma was further evaluated by polyacrylamide gel electrophoresis, showing the presence of both intact GEM 91 and lower molecular weight metabolites. Urinary excretion represented the major pathway of elimination, with 49.15% +/- 6.80% of the administered dose excreted within 24 hours and 70.37% +/- 6.72% over 96 hours after dosing. The radioactivity in urine was associated with lower molecular weight metabolites. No drug-related toxicity was observed.
    23 schema:genre article
    24 schema:isAccessibleForFree false
    25 schema:isPartOf N455a053d974d49678a19689e856eb84c
    26 N5ef100c3a5bb49e39041502ad45db299
    27 sg:journal.1017409
    28 schema:keywords GEM 91
    29 HIV
    30 administered dose
    31 agents
    32 anti-human immunodeficiency virus agents
    33 antisense oligodeoxynucleotide phosphorothioate
    34 curves
    35 disappearance curve
    36 dose
    37 drug-related toxicity
    38 electrophoresis
    39 elimination
    40 excretion
    41 exponential
    42 gel electrophoresis
    43 half-life values
    44 hours
    45 human pharmacokinetics
    46 individuals
    47 infusion
    48 intravenous infusion
    49 low molecular weight metabolites
    50 major pathway
    51 means
    52 metabolites
    53 oligodeoxynucleotide phosphorothioates
    54 pathway
    55 pharmacokinetics
    56 phosphorothioate
    57 plasma
    58 plasma disappearance curve
    59 polyacrylamide gel electrophoresis
    60 presence
    61 radioactivity
    62 study
    63 subjects
    64 sum
    65 toxicity
    66 urinary excretion
    67 urine
    68 values
    69 virus agents
    70 weight metabolites
    71 schema:name Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV‐infected subjects
    72 schema:pagination 44-53
    73 schema:productId N65f11717649d4f6397eeeb8554468d81
    74 Nd02dc626310f40b788142d4ea0705226
    75 Ne3a734dac8e246a4b98741840a93570e
    76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026112658
    77 https://doi.org/10.1016/0009-9236(95)90071-3
    78 schema:sdDatePublished 2022-11-24T20:48
    79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    80 schema:sdPublisher N4f1061735e324f52bff2caaafad51da0
    81 schema:url https://doi.org/10.1016/0009-9236(95)90071-3
    82 sgo:license sg:explorer/license/
    83 sgo:sdDataset articles
    84 rdf:type schema:ScholarlyArticle
    85 N040aa22c4fae42daba59b99a0b411c6b rdf:first sg:person.01214146430.55
    86 rdf:rest rdf:nil
    87 N0534f588f6c64319ac520fa9a5300752 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    88 schema:name Humans
    89 rdf:type schema:DefinedTerm
    90 N0a6bb8b81ed249849321686b332f814c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    91 schema:name Tissue Distribution
    92 rdf:type schema:DefinedTerm
    93 N19e4e23bb383473dabf050c848ad5a39 rdf:first sg:person.01124454740.04
    94 rdf:rest N040aa22c4fae42daba59b99a0b411c6b
    95 N1ee93fcbd2b04240be966bf59305fd10 rdf:first sg:person.0671453264.03
    96 rdf:rest Ne5eca5aa00124e819aad61bd6888d8dd
    97 N24e2e7af20144cbc825490b2e487f22c schema:affiliation grid-institutes:grid.452508.e
    98 schema:familyName Saag
    99 schema:givenName Michael S.
    100 rdf:type schema:Person
    101 N42aaad23e74f4e40aa794b7245d32942 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name Chromatography, High Pressure Liquid
    103 rdf:type schema:DefinedTerm
    104 N44de35d3de9f436db3d55a66eba21034 rdf:first sg:person.011364334577.13
    105 rdf:rest N7830ba6e90fd4fd3ac21e959c4d04a80
    106 N455a053d974d49678a19689e856eb84c schema:issueNumber 1
    107 rdf:type schema:PublicationIssue
    108 N4cc1358fdca848d68f5b86a7c640f691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Base Sequence
    110 rdf:type schema:DefinedTerm
    111 N4f1061735e324f52bff2caaafad51da0 schema:name Springer Nature - SN SciGraph project
    112 rdf:type schema:Organization
    113 N5d04996050a946999641942559e6ce75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    114 schema:name HIV Infections
    115 rdf:type schema:DefinedTerm
    116 N5d8add12f3d94da89329760db6c5aa30 schema:affiliation grid-institutes:grid.452508.e
    117 schema:familyName Amin
    118 schema:givenName Girish
    119 rdf:type schema:Person
    120 N5ef100c3a5bb49e39041502ad45db299 schema:volumeNumber 58
    121 rdf:type schema:PublicationVolume
    122 N65edff04ac0e4bfa84037026ca00380b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Male
    124 rdf:type schema:DefinedTerm
    125 N65f11717649d4f6397eeeb8554468d81 schema:name doi
    126 schema:value 10.1016/0009-9236(95)90071-3
    127 rdf:type schema:PropertyValue
    128 N66cf4b0d0e3743c2968aaec03742fe63 rdf:first N24e2e7af20144cbc825490b2e487f22c
    129 rdf:rest Nbae41cd165e1414ba62544c8f87fd962
    130 N7830ba6e90fd4fd3ac21e959c4d04a80 rdf:first sg:person.01331501663.41
    131 rdf:rest N1ee93fcbd2b04240be966bf59305fd10
    132 N7f0d4c29d41d4e55875e891d3e1a857d rdf:first sg:person.01165601710.13
    133 rdf:rest N66cf4b0d0e3743c2968aaec03742fe63
    134 N86c59def7e8d4ef8ad639827c30beebf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Antiviral Agents
    136 rdf:type schema:DefinedTerm
    137 N8813e100c36d4b23a88a24342fd2e179 rdf:first sg:person.0703710210.14
    138 rdf:rest Na0f3a29d27764697aab726863b745b8b
    139 Na0f3a29d27764697aab726863b745b8b rdf:first sg:person.01352605264.31
    140 rdf:rest Nd193accc4fcf47569a20e45a4c58046e
    141 Na6ae597615aa48d1afa2aa0eeca5dfc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Adult
    143 rdf:type schema:DefinedTerm
    144 Nabef95996c1344a797d38c6d94690330 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Electrophoresis, Polyacrylamide Gel
    146 rdf:type schema:DefinedTerm
    147 Nb3430826d1354c5fb4770dad7a05c137 rdf:first sg:person.01306056120.26
    148 rdf:rest N7f0d4c29d41d4e55875e891d3e1a857d
    149 Nb58879739c514dc1b5521079e1f7f88e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Sulfur Radioisotopes
    151 rdf:type schema:DefinedTerm
    152 Nb865a0d0373a46f797481083adc4e13f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Oligonucleotides, Antisense
    154 rdf:type schema:DefinedTerm
    155 Nbae41cd165e1414ba62544c8f87fd962 rdf:first sg:person.016234157744.48
    156 rdf:rest N8813e100c36d4b23a88a24342fd2e179
    157 Nc000fd6f9115436abd97837b7deae83d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Infusions, Intravenous
    159 rdf:type schema:DefinedTerm
    160 Nc4630672d6ce4522adc54b9a93cddcdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name Oligodeoxyribonucleotides, Antisense
    162 rdf:type schema:DefinedTerm
    163 Nd02dc626310f40b788142d4ea0705226 schema:name pubmed_id
    164 schema:value 7628182
    165 rdf:type schema:PropertyValue
    166 Nd193accc4fcf47569a20e45a4c58046e rdf:first sg:person.01106771602.20
    167 rdf:rest N19e4e23bb383473dabf050c848ad5a39
    168 Nd9601b3ff28440679bf0ffc41691b773 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Thionucleotides
    170 rdf:type schema:DefinedTerm
    171 Ndab48c3d4809489f827bd243a15b1c93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Molecular Sequence Data
    173 rdf:type schema:DefinedTerm
    174 Ne3a734dac8e246a4b98741840a93570e schema:name dimensions_id
    175 schema:value pub.1026112658
    176 rdf:type schema:PropertyValue
    177 Ne5eca5aa00124e819aad61bd6888d8dd rdf:first N5d8add12f3d94da89329760db6c5aa30
    178 rdf:rest Nb3430826d1354c5fb4770dad7a05c137
    179 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    180 schema:name Medical and Health Sciences
    181 rdf:type schema:DefinedTerm
    182 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
    183 schema:name Medical Microbiology
    184 rdf:type schema:DefinedTerm
    185 sg:journal.1017409 schema:issn 0009-9236
    186 1532-6535
    187 schema:name Clinical Pharmacology & Therapeutics
    188 schema:publisher Springer Nature
    189 rdf:type schema:Periodical
    190 sg:person.01106771602.20 schema:affiliation grid-institutes:grid.452508.e
    191 schema:familyName Schechter
    192 schema:givenName Paul J.
    193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106771602.20
    194 rdf:type schema:Person
    195 sg:person.01124454740.04 schema:affiliation grid-institutes:grid.452508.e
    196 schema:familyName Agrawal
    197 schema:givenName Sudhir
    198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04
    199 rdf:type schema:Person
    200 sg:person.011364334577.13 schema:affiliation grid-institutes:grid.452508.e
    201 schema:familyName Zhang
    202 schema:givenName Ruiwen
    203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011364334577.13
    204 rdf:type schema:Person
    205 sg:person.01165601710.13 schema:affiliation grid-institutes:grid.452508.e
    206 schema:familyName Liu
    207 schema:givenName Tiepu
    208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165601710.13
    209 rdf:type schema:Person
    210 sg:person.01214146430.55 schema:affiliation grid-institutes:grid.452508.e
    211 schema:familyName Diasio
    212 schema:givenName Robert B.
    213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214146430.55
    214 rdf:type schema:Person
    215 sg:person.01306056120.26 schema:affiliation grid-institutes:grid.452508.e
    216 schema:familyName Lu
    217 schema:givenName Zhihong
    218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306056120.26
    219 rdf:type schema:Person
    220 sg:person.01331501663.41 schema:affiliation grid-institutes:grid.452508.e
    221 schema:familyName Yan
    222 schema:givenName Jieming
    223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331501663.41
    224 rdf:type schema:Person
    225 sg:person.01352605264.31 schema:affiliation grid-institutes:grid.452508.e
    226 schema:familyName Martin
    227 schema:givenName R. Russell
    228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352605264.31
    229 rdf:type schema:Person
    230 sg:person.016234157744.48 schema:affiliation grid-institutes:grid.452508.e
    231 schema:familyName Jiang
    232 schema:givenName Zhiwei
    233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016234157744.48
    234 rdf:type schema:Person
    235 sg:person.0671453264.03 schema:affiliation grid-institutes:grid.452508.e
    236 schema:familyName Shahinian
    237 schema:givenName Harout
    238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671453264.03
    239 rdf:type schema:Person
    240 sg:person.0703710210.14 schema:affiliation grid-institutes:grid.452508.e
    241 schema:familyName Temsamani
    242 schema:givenName Jamal
    243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703710210.14
    244 rdf:type schema:Person
    245 sg:pub.10.1385/0-89603-281-7:33 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014426169
    246 https://doi.org/10.1385/0-89603-281-7:33
    247 rdf:type schema:CreativeWork
    248 grid-institutes:grid.452508.e schema:alternateName Hybridon, Inc., Worcester, Mass., USA
    249 schema:name AIDS Center, University of Alabama at Birmingham, Birmingham, Ala., USA
    250 Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala., USA
    251 Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Ala., USA
    252 Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Ala., USA
    253 Hybridon, Inc., Worcester, Mass., USA
    254 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...